Istavet Tablets 25 Mg

Istavet Tablets 25 Mg

Istavet Tablets 25 Mg is an oral anti-diabetic medication used for the management of type 2 diabetes mellitus. It contains sitagliptin, a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood sugar levels by increasing insulin release and decreasing glucose production in the body. This medication is commonly prescribed when diet and exercise alone are not sufficient to control blood sugar. It is often used as monotherapy or in combination with other anti-diabetic drugs. In treatment plans, medications like Acarbose Tablets 25 Mg and combination therapies such as Diabetes – Janumet Tablets 50/500 Mg are also used for improved glycemic control.

Mechanism of Action

DPP-4 Inhibition

Istavet works by inhibiting the DPP-4 enzyme, which increases incretin hormone levels.

Improved Insulin Response

This enhances insulin secretion and reduces glucose production, especially after meals. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Sitagliptin Information.

Medical Uses

Istavet Tablets 25 Mg is used for:

• Type 2 diabetes mellitus
• Blood sugar control
• Combination therapy with other antidiabetic medications

It is commonly prescribed for long-term diabetes management.

Dosage and Administration

Istavet Tablets 25 Mg is usually taken once daily, with or without food, as directed by a healthcare provider. The dosage may vary depending on kidney function and patient response. In clinical practice, Acarbose Tablets 25 Mg may be used for post-meal glucose control, while Diabetes – Janumet Tablets 50/500 Mg is prescribed for combination therapy to achieve better glycemic outcomes.

Clinical Effectiveness

Clinical studies show that sitagliptin effectively lowers blood sugar levels, particularly post-meal glucose, and helps maintain overall glycemic control when used consistently.

Safety and Side Effects

Common Side Effects

• Headache
• Nasal congestion
• Upper respiratory symptoms

Serious Risks

• Pancreatitis (rare)
• Severe allergic reactions

Regular monitoring is recommended. For more details, refer to Mayo Clinic – Sitagliptin Information.

Contraindications and Precautions

Istavet Tablets 25 Mg should be used with caution in:

• Patients with kidney disease
• Individuals with a history of pancreatitis
• Pregnant or breastfeeding women

Consult a healthcare provider before use.

Drug Interactions

Istavet may interact with other antidiabetic medications, potentially increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medications they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs